GHK-Cu 50 mg
$27.00
Kalpa Pharmaceuticals GHK-CU 50 mg – Copper Peptide for Tissue Regeneration
Kalpa Pharmaceuticals GHK-CU 50 mg is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that has garnered significant attention in wound healing and tissue regeneration research. Each 2 mL vial contains 50 mg of lyophilized GHK-CU, ready for reconstitution with bacteriostatic water for laboratory studies.
This peptide is recognized for its ability to modulate gene expression related to tissue repair, inflammation, and collagen production. For researchers investigating dermal regeneration or systemic tissue recovery, GHK-CU offers a unique copper-dependent mechanism distinct from other repair-focused peptides. Explore similar research compounds like BPC 157 5 mg or TB 500 5 mg.
What Makes Kalpa Pharmaceuticals GHK-CU Unique?
Unlike many synthetic peptides, GHK-CU is a matrikine — a peptide fragment naturally released during tissue injury that signals repair processes. Its copper-binding capacity is essential for its biological activity, influencing copper-dependent enzymes involved in extracellular matrix remodeling and antioxidant defense.
For performance-focused research, GHK-CU is often studied alongside Ipamorelin 5 mg to evaluate combined effects on recovery and tissue integrity. The 50 mg dosage provides ample material for extended research protocols or multi-subject studies.
Benefits of Kalpa Pharmaceuticals GHK-CU for Research
- ✔ Supports wound healing and tissue remodeling studies
- ✔ Copper-bound form for biologically relevant research
- ✔ 50 mg lyophilized powder for long-term storage stability
- ✔ Suitable for subcutaneous or topical administration research
- ✔ Can be combined with BPC-157 for comprehensive repair models
Kalpa Pharmaceuticals GHK-CU 50 mg is intended for laboratory research only. Not for human consumption or clinical use.
External research on GHK-CU's mechanisms can be explored via PubMed for peer-reviewed studies.